GLYPROFIL M - MEDICATED COLLAGEN PARTICLES is a cutting-edge collagen wound dressing developed by Regenxgen Biosolutions Private Limited, specifically designed to address a variety of challenging wound types. This advanced dressing is particularly effective for managing infected and chronic non-healing ulcers, diabetic ulcers, venous leg ulcers, decubitus ulcers, dehised skin, necrotizing fasciitis, toxic epidermal necrolysis, and dermatological wounds such as epidermolysis bullosa and pemphigus vulgaris. The formulation of GLYPROFIL M incorporates potent antibiotics, Mupirocin and Metronidazole, which are effective against both Gram-positive and Gram-negative bacteria, as well as anaerobic bacteria commonly found in infected ulcers. This dual-action antibiotic approach not only helps in controlling infection but also promotes a conducive environment for wound healing. The dressing stimulates healthy granulation tissue formation and accelerates the wound closure process, optimizing the wound pH to enhance healing outcomes. GLYPROFIL M is 100% resorbable, ensuring that it integrates seamlessly into the healing process without leaving any residual materials. It is available in multiple sizes, including 5ml, 10ml, and 15ml, catering to various wound sizes and treatment needs.
